This inventor holds 3 USPTO granted patents and 1 published patent application and 6 EPO patents. Top assignees: National Institute of Health and Medical Research, Assistance Publique-Hopitaux De Paris, Université Paris Descartes. Active years: 2016-2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
3 out of 1,853 
1 out of 331 
1 out of 132 
Years Active: 2016-2018
Title: Frédéric Jaisser: Innovator in Heart Failure Treatment
Introduction
Frédéric Jaisser is a prominent inventor based in Paris, France. He has made significant contributions to the field of medical research, particularly in the treatment of heart failure. With a total of 3 patents, Jaisser's work focuses on innovative methods that aim to improve patient outcomes.
Latest Patents
Jaisser's latest patents include a method for the treatment of heart failure. This invention relates to an inhibitor of NGAL gene expression or a NGAL antagonist for use in the prevention or treatment of heart failure. His work emphasizes the importance of targeting specific genetic expressions to combat this serious health condition.
Career Highlights
Throughout his career, Frédéric Jaisser has worked with esteemed organizations such as the Institut National de la Santé et de la Recherche Médicale and Assistance Publique-Hôpitaux de Paris. His experience in these institutions has allowed him to collaborate with leading experts in the medical field and contribute to groundbreaking research.
Collaborations
Some of Jaisser's notable coworkers include Nicolette Farman and Francine Behar-Cohen. Their collaborative efforts have further advanced the research and development of innovative treatments for heart failure.
Conclusion
Frédéric Jaisser's contributions to the field of heart failure treatment through his patents and collaborations highlight his dedication to improving healthcare. His innovative approaches continue to pave the way for future advancements in medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile